Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor
US9925232B2 · kind B2 · utility
2Cited by
20References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2014 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Jul 23, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods and compositions for use of desmopressin in combination with a 5-alpha reductase inhibitor. The methods and compositions are useful in the treatment of nocturia and other urinary frequency disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.